Exosome Hair Therapy in Multan: Evidence Before Marketing

Exosomes are extracellular vesicles that play a role in cell-to-cell signalling. That biological function doesn't mean that a commercial vial will turn hair loss around. There are various differences between products, such as cell source, processing, concentration, and storage and delivery, and limited evidence for human hair-regrowth. The hair therapy using exosomes in Multan is therefore more of an investigational treatment than one that is proven. Before needling or injecting any product labeled as “regenerative,” a diagnosis of the scalp should be conducted, along with a thorough product history.

What is known, and yet remains unknown.

Laboratory research investigates the effects that proteins (lipids and others) that may carry a signaling function have on dermal papilla cells or the hair cycle. That initial mechanism gets misapplied in marketing as ‘follicle activation’, but no reliable dose, schedule, long-term safety and predictable density improvement is known across commercial products.

An exosome product can be made from a different body cell source than the patient's own blood, which is used for making PRP. Manufacturer Control, Sterility, Batch Consistency and Cold Chain Handling are important. The US FDA reports that there are no FDA-approved exosome products, and has cautioned about the serious consequences of using unapproved products. The evidence and traceability discussion is separate from Pakistani regulation, but the warning is still valid.

How often should you get hair treatments at exosome centre in Multan?How many times should you visit exosome centre Multan for a hair treatment?

Patients should ask for exact product, manufacturer, source material, batch, whether it has been locally registered or not and the evidence and records of its use on the scalp. The term "stem-cell derived" isn't specific enough. Consent should indicate if the vial will be applied after microneedling or injected, as this will involve different exposure and procedure risks.

The clinic should tell who provided and stored the product, how a recall would be done and what would happen if no response is received. The increased price or increased particle count doesn't necessarily indicate purity or efficacy.

The real treatment is determined by diagnosis.

There are four types of baldness that require different treatments—Androgenetic alopecia, Telogen effluvium, Alopecia areata and Scalp fungus and scarring inflammation. There is no serum that can replace a disease which is doing its damage on follicles. History and selective tests, along with trichoscopy may help determine a more supportive treatment or indicate that an elective procedure is not the correct treatment.

Exosome scalp products are an uncertain option in a market that often moves faster than clinical evidence. Patients should not rely on the word “regenerative” without a diagnosis, traceable vial and realistic stop rule. Established therapy for the actual hair-loss condition should remain the main comparison, not an afterthought. That distinction matters.